- Home
- OSCR vs PTGX Comparison
OSCR vs PTGX Comparison
Compare OSCR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSCR | PTGX |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.1B |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | OSCR | PTGX |
|---|---|---|
| Price | $14.86 | $82.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $17.00 | ★ $93.00 |
| AVG Volume (30 Days) | ★ 8.2M | 788.9K |
| Earning Date | 02-10-2026 | 02-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | ★ $11,288,628,000.00 | $209,217,000.00 |
| Revenue This Year | $33.58 | N/A |
| Revenue Next Year | $4.55 | $409.41 |
| P/E Ratio | ★ N/A | $115.35 |
| Revenue Growth | ★ 37.38 | N/A |
| 52 Week Low | $11.20 | $33.70 |
| 52 Week High | $23.80 | $96.54 |
Technical Indicators
Market Signals| Indicator | OSCR | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 40.12 | 44.12 |
| Support Level | $14.80 | $81.94 |
| Resistance Level | $18.20 | $85.50 |
| Average True Range (ATR) | 0.86 | 3.16 |
| MACD | -0.19 | 0.02 |
| Stochastic Oscillator | 3.05 | 40.39 |
Price Performance
Historical ComparisonAbout OSCR Oscar Health Inc.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.